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apy (ATT) develop DF, dengue haemorrhagic fever (DHF) and
dengue shock syndrome (DSS). We performed a retrospective
review of the management of DF, DHF and DSS in patients
receiving ATT.
Methods: Files with a discharge code of DF from Novem-
ber 2002 to October 2007 were matched with individuals
on ATT. Each case was examined for clinical features con-
sistent with concurrent DF and ATT. Cases were accepted
only if they had fever, haemoconcentration, fall and rise in
platelets, and a positive conﬁrmatory Dengue assay (dengue
IgM or antigen).
Results: 55 individuals were identiﬁed. 45 patients were
excluded because of inconsistent clinical features (9),
non-concurrent ATT (27), unavailable ﬁles (1), lack of con-
ﬁrmatory dengue assay (8). Ten patients were accepted.
All received warfarin. 4 had mechanical prosthetic heart
valve; 3 had atrial ﬁbrillation; 1 had ischemic cardiomy-
opathy; 1 had recurrent pulmonary embolism; 1 had severe
peripheral vascular disease. 9 patients had positive conva-
lescent dengue IgM; 1 had positive dengue antigen. 7 had
DF, 2 had DHF, 1 had DSS. On admission, median platelet
counts was 87,000/mm3 (range 55,000—195,000/mm3);
median INR 1.66 (range 1.10—2.87). 7 patients had their
warfarin discontinued. 4 received platelets for throm-
bocytopaenia (< 29,000/mm3); 3 received vitamin K; 2
received fresh frozen plasma (FFP). 3 patients continued
their warfarin as they were not over-anticoagulated and
had no bleeding complications. None developed throm-
botic complications. Warfarin was restarted when platelets
exceeded 42,000/mm3. The median nadir platelet count was
33,000/mm3 (7,000—95,000/mm3).
Conclusion: Temporary discontinuation of anticoagula-
tion treatment may be necessary in patients with DF, DHF
or DSS. This was not associated with thrombotic events.
Correction of thrombocytopenia and coagulopathy is recom-
mended in the presence of haemorrhage.
doi:10.1016/j.ijid.2008.05.816
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General Practitioners and Medical Student’s Knowledge
and Perspectives Regarding Inﬂuenza (Treatment and Pre-
vention)
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Intruduction: Inﬂuenza is a viral disease of the upper
respiratory tract and has a high prevalence in autumn
and winter. Although inﬂuenza medical treatment has
improved, but a considerable rate of mortality (especially
in high risk group) occur each year during the inﬂuenza
epidemics. Inﬂuenza vaccination rate in high risk group
is very low (<5%). It sounds that lack of knowledge or
attention to inﬂuenza prevention and management in our
physicians.
Method & Materials: A questionnaire was distributed to
a random sampling of general practitioners and medical
students in three teaching hospitals of Mazandaran Univer-
sity of medical science. Questions were asked regarding,
general information about inﬂuenza, treatment, current
use of inﬂuenza vaccines, medical prevention, and knowl-
edge regarding avian inﬂuenza. Answers were scored as
correct based on published literature and CDC recom-
mendations. The data were statistically analyzed using
SPSS(ver,10) and we use Chi-square to compare two
groups.
Results: The knowledge level of medical students and
general practitioners regarding ﬂue and vaccination indi-
cations was comparable. The majority of physicians were
not aware of the severity of inﬂuenza infection in young
children, could not correctly identify all contraindications
to receiving vaccination and their knowledge regarding
chemoprophylaxis was not acceptable. However, on medi-
cal treatment and prevention general physicians had higher
level of knowledge (p < 0.01), while medical students were
better in avian inﬂuenza (p < 0.001).
doi:10.1016/j.ijid.2008.05.817
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The problem of infectious mononucleosis (IM) is very
important today due to the increase of morbidity in Ukraine,
the variety and variability of clinical manifestations, depres-
sion of immunity and ability of turning into a chronic form
of Epstein-Barr virus infection (EBV-infection). To charac-
terize the frequency of transition into a chronic form of
EBV-infection 100 patients with acute IM (45 male and 55
female), aged 17—45, were analyzed, serologically and clin-
ically, during 5 years period (2002—2007).
Typical clinical manifestations with moderate course
were detected in 84% of patients with next clinical ﬁndings:
fever, the symptoms of general intoxication, pharyngitis,
lymphadenopathy, hepatomegaly, splenomegaly, lympho-
cytosis, monocytosis and atypical large cells. Clinical
course had prominent features: acute beginning of dis-
ease, frequent cases of rash, frequent ﬁndings of different
microbes’ associations from nasopharynx, increased number
of patients with diffuse lesions of the liver. 73,0% of investi-
gated had the chronic diseases of respiratory tract, 48,0% -
involvement of digestive tract, 21% - involvement of urino-
genital system, 18,0% - endocrine system, 6,0% - nervous
system, 25,0% of investigated - allergic reactions in medical
history. Chronic somatic diseases were registered in 78,0% of
investigated, which statistically had inﬂuence on the clinical
course severity.
During the dynamic follow-up of patients with chronic IM
it was showed that in a group of patients clinical and labo-
ratory signs of EBV-infection still remained: at the patient’s
discharge from the hospital - 55,0%, after 1 year - 83,0%,
in two years - 76,0%, in three years - 50,0%, in ﬁve years -
28,1%.
In the long-term follow-up (5 years) next forms of chronic
EBV-infection were registered: latent form - 25,6%, reacti-
vation - 46,3%, chronic effaced form - 28,1%, chronic active
form - 9,7%. Received data indicate that long-term follow-up
of patients with chronic EBV infection is necessary and can
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bring to individual treatment options and rational follow-up
duration.
doi:10.1016/j.ijid.2008.05.818
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Rna Interference Mediated Silencing of Hsp60 and 70
Genes in Human Monocytes Reveals Decreased Dengue
Virus Multiplication
L. Ganju
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Heat Shock Proteins (Hsps) or stress proteins are highly
conserved molecules and expressed in all cell types under
stressful conditions like heat, cold, hypoxia and infections.
The objective of the present study was to determine the
effect of Dengue virus infection on relative expression of
stress proteins and their role in the progression of the infec-
tion. As macrophages are the primary host for Dengue,
human promonocytic myeloblastoma U937 cells, monocytic
THP1 cells and blood derived macrophages were infected
with Dengue virus type 2 New Guinea strain for the evalua-
tion of Hsp expression. A signiﬁcant expression of Hsp60 was
observed in virally infected U937 cells where as Hsp70 was
predominantly expressed in blood derived macrophages and
THP1 as compared to controls. In order to determine the
correlation between Hsp60/70 expressions and viral multi-
plication in infected cells, expression of Hsp60 and 70 was
down regulated by RNA interference. Viral multiplication
was determined by quantiﬁcation of viral RNA copy number
using Real Time PCR and plaque formation assay in culture
supernatants of Hsp60 and 70 silenced cells. Intracellular
quantiﬁcation of viral load was also determined by ﬂow
cytometry. It was observed that down regulation of Hsp60
and 70 in virally infected cells resulted into decrease in
viral RNA copy number and intracellular viral load. At the
same time down regulation of Hsp60 and 70 expressions also
resulted in increased IFN- level which mediate its antiviral
effect through double stranded RNA induced protein kinase
(PKR). These observations suggest that, elevation of Hsp60
and 70 expressions in virally infected cells may help in viral
multiplication and could be possible therapeutic targets for
the management of Dengue virus infection.
doi:10.1016/j.ijid.2008.05.819
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Malaria remains one of the leading public health prob-
lems in Cameroon as in other parts of Sub-Saharan Africa.
In the past decades, this situation has been aggravated by
the increasing spread of drug-resistant Plasmodium falci-
parum strains. New antimalarial drug leads are therefore
urgently needed. Traditional healers have long used plants
to prevent or cure infections. This article reviews the cur-
rent status of botanical screening efforts in Cameroon as
well as experimental studies done on antimalarial plants.
Data collected from 53 references of various research groups
in the literature up to June 2007 shows that 217 differ-
ent species have been identiﬁed in Cameroon for their use
as antimalarials in folk medicine. About a hundred phyto-
chemicals have been isolated from 26 species some of which
are potential leads for development of new antiamalari-
als. Crude extracts and or essential oils prepared from 54
other species showed a wide range of activity on Plasmod-
ium spp. Moreover, some 137 plants from 48 families that are
employed by traditional healers remain uninvestigated for
their presumed antimalarial properties. The present study
shows that Cameroonian ﬂora represents a high potential
for new antimalarial compounds. Further ethno botanical
surveys and laboratory investigations are needed to fully
exploit the potential of the identiﬁed species in the control
of malaria.
doi:10.1016/j.ijid.2008.05.820
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Apical membrane antigen 1 (AMA1) is a promising vaccine
candidate, and a number of vaccines based on this molecule
are currently at different stages of clinical trials. Prior infor-
mation of the genetic repertoire of the natural Plasmodium
populations helps in the development of malaria vaccines.
Accumulating evidence suggests that allelic variations in
the antigens may inﬂuence immunogenicity and protective
effect of a vaccine. In a comprehensive and comparative
study we have analyzed extent of polymorphisms and nat-
ural selection at P. falciparum and P. vivax AMA1 among
Indian populations. We sequenced domain I of P. falciparum
AMA1 while both domain I and II of P. vivax AMA1. Sequenc-
ing data were analyzed using DnaSP and MEGA3 packages.
Signatures of selection on these antigens were estimated
by the ratio of non-synonymous (dN) and synonymous (dS)
mutations as well as Tajima’s D and McDonald-Kreitman test
statistics. Three-dimensional structures of AMA1 were made
using MODELLER routine incorporated in Discovery studio. A
total of 57 AMA1 haplotypes with 29 polymorphic residues
were found among 157 P. falciparum isolates. Whereas 49
haplotypes with 25 polymorphic residues were found among
61 P. vivax isolates. Most of the observed haplotypes from
both species were new as they have not been reported from
any other regions. The dN-dS difference for PfAMA1 domain
I and PvAMA1 domain II were found to be positive, indicating
that they are under positive natural selection while, it was
negative for PvAMA1 domain I. Results from PfAMA1 show
moderate level of genetic differentiation and limited gene
ﬂow between populations. Three-dimensional structures of
both antigens predicted that all polymorphic residues were
found to be distributed at only one surface of the molecule.
